heart failureLife After Avandia: New Diabetes Drugs Will Face Tougher Testing for Heart-Failure Risks
In the wake of widespread reports of heart failures, liver damage, and other patient injuries and seemingly non-stop controversy surrounding the top-selling type-2 diabetes drug Avandia, the Food and Drug Administration now says that future diabetes drugs will face much tougher scrutiny.




facebook
rss
twitter